The University of Southampton
University of Southampton Institutional Repository

Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma

Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma
Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma
Purpose

To study the clinical significance of transformation to diffuse large B-cell lymphoma (DLBCL) in patients with follicular lymphoma (FL).

Patients and Methods

From 1972 to 1999, 325 patients were diagnosed with FL at St Bartholomew's Hospital (London, United Kingdom). With a median follow-up of 15 years, progression occurred in 186 patients and biopsy-proven transformation in 88 of the 325. The overall repeat biopsy rate was 70%.

Results

The risk of histologic transformation (HT) by 10 years was 28%, HT not yet having been observed after 16.2 years. The risk was higher in patients with advanced stage (P = .02), high-risk Follicular Lymphoma International Prognostic Index (FLIPI; P = .01), and International Prognostic Index (IPI; P = .04) scores at diagnosis. Expectant management (as opposed to treatment being initiated at diagnosis) also predicted for a higher risk of HT (P = .008). Older age (P = .005), low hemoglobin level (P = .03), high lactate dehydrogenase (P < .0001), and high-risk FLIPI (P = .01) or IPI (P = .003) score at the time of first recurrence were associated with the diagnosis of HT in a biopsy performed at that time. The median survival from transformation was 1.2 years. Patients with HT had a shorter overall survival (P < .0001) and a shorter survival from progression (P < .0001) than did those in whom it was not diagnosed.

Conclusion

Advanced stage and high-risk FLIPI and IPI scores at diagnosis correlate with an increased risk of HT. This event strongly influences the outcome of patients with FL by shortening their survival. There may be a subgroup of patients in whom HT does not occur.

1527-7755
2426-2433
Montoto, S.
c05d6ef0-61e9-4ab0-8e70-1facb965bbff
Davies, A.J.
0fe6a40a-10d1-4ade-a7e6-d1dceb2470af
Matthews, J.
4c708491-7509-44d6-9375-2b7313a36f3e
Calaminici, M.
aaffc1c1-a95f-4119-9107-92f6d7ea6de0
Norton, A.J.
fe7d8253-bcfa-4789-9397-4001b795d75c
Amess, J.
71bf8bdf-5591-4bde-871f-412789768219
Vinnicombe, S.
76f44048-c7f0-4a79-968c-41d7ece30e6b
Waters, R.
c3ee773b-882c-41ea-84ee-20a5009d5a51
Rohatiner, A.Z.
6555b742-d414-4fcb-908f-f43b6de8b71a
Lister, T.A.
ffe041c9-eb11-47e8-8c7c-177f8bc193c9
Montoto, S.
c05d6ef0-61e9-4ab0-8e70-1facb965bbff
Davies, A.J.
0fe6a40a-10d1-4ade-a7e6-d1dceb2470af
Matthews, J.
4c708491-7509-44d6-9375-2b7313a36f3e
Calaminici, M.
aaffc1c1-a95f-4119-9107-92f6d7ea6de0
Norton, A.J.
fe7d8253-bcfa-4789-9397-4001b795d75c
Amess, J.
71bf8bdf-5591-4bde-871f-412789768219
Vinnicombe, S.
76f44048-c7f0-4a79-968c-41d7ece30e6b
Waters, R.
c3ee773b-882c-41ea-84ee-20a5009d5a51
Rohatiner, A.Z.
6555b742-d414-4fcb-908f-f43b6de8b71a
Lister, T.A.
ffe041c9-eb11-47e8-8c7c-177f8bc193c9

Montoto, S., Davies, A.J., Matthews, J., Calaminici, M., Norton, A.J., Amess, J., Vinnicombe, S., Waters, R., Rohatiner, A.Z. and Lister, T.A. (2007) Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. Journal of Clinical Oncology, 25 (17), 2426-2433. (doi:10.1200/JCO.2006.09.3260).

Record type: Article

Abstract

Purpose

To study the clinical significance of transformation to diffuse large B-cell lymphoma (DLBCL) in patients with follicular lymphoma (FL).

Patients and Methods

From 1972 to 1999, 325 patients were diagnosed with FL at St Bartholomew's Hospital (London, United Kingdom). With a median follow-up of 15 years, progression occurred in 186 patients and biopsy-proven transformation in 88 of the 325. The overall repeat biopsy rate was 70%.

Results

The risk of histologic transformation (HT) by 10 years was 28%, HT not yet having been observed after 16.2 years. The risk was higher in patients with advanced stage (P = .02), high-risk Follicular Lymphoma International Prognostic Index (FLIPI; P = .01), and International Prognostic Index (IPI; P = .04) scores at diagnosis. Expectant management (as opposed to treatment being initiated at diagnosis) also predicted for a higher risk of HT (P = .008). Older age (P = .005), low hemoglobin level (P = .03), high lactate dehydrogenase (P < .0001), and high-risk FLIPI (P = .01) or IPI (P = .003) score at the time of first recurrence were associated with the diagnosis of HT in a biopsy performed at that time. The median survival from transformation was 1.2 years. Patients with HT had a shorter overall survival (P < .0001) and a shorter survival from progression (P < .0001) than did those in whom it was not diagnosed.

Conclusion

Advanced stage and high-risk FLIPI and IPI scores at diagnosis correlate with an increased risk of HT. This event strongly influences the outcome of patients with FL by shortening their survival. There may be a subgroup of patients in whom HT does not occur.

This record has no associated files available for download.

More information

Published date: June 2007

Identifiers

Local EPrints ID: 73259
URI: http://eprints.soton.ac.uk/id/eprint/73259
ISSN: 1527-7755
PURE UUID: 1581df1d-f8ec-48eb-b64a-cbfeaa20fda0
ORCID for A.J. Davies: ORCID iD orcid.org/0000-0002-7517-6938

Catalogue record

Date deposited: 04 Mar 2010
Last modified: 14 Mar 2024 02:54

Export record

Altmetrics

Contributors

Author: S. Montoto
Author: A.J. Davies ORCID iD
Author: J. Matthews
Author: M. Calaminici
Author: A.J. Norton
Author: J. Amess
Author: S. Vinnicombe
Author: R. Waters
Author: A.Z. Rohatiner
Author: T.A. Lister

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×